Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Biosynthesis, bioactivity, biotoxicity and applications of antimicrobial peptides for human health
Antimicrobial peptides (AMPs) are the natural antibiotics recognized for their broad-
spectrum resistance to bacteria, fungi, viruses and parasites, and influencing the host …
spectrum resistance to bacteria, fungi, viruses and parasites, and influencing the host …
Real-world use of dalbavancin in the era of empowerment of outpatient antimicrobial treatment: a careful appraisal beyond approved indications focusing on unmet …
Dalbavancin is a novel, long-acting lipoglycopeptide characterized by a long elimination half-
life coupled with excellent in vitro activity against multidrug-resistant Gram-positives …
life coupled with excellent in vitro activity against multidrug-resistant Gram-positives …
[HTML][HTML] EN-DALBACEN 2.0 Cohort: Real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive …
Objectives Infective endocarditis (IE) has high mortality and morbidity and requires long
hospital stays to deliver the antibiotic treatment recommended in clinical practice guidelines …
hospital stays to deliver the antibiotic treatment recommended in clinical practice guidelines …
[PDF][PDF] The current and future off-label uses of dalbavancin: A narrative review
A De Vito, V Fiore, A Colpani, B Zauli… - Eur. Rev. Med …, 2023 - europeanreview.org
Dalbavancin is a novel long-acting semi-synthetic lipoglycopeptide. It is licensed for acute
bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive …
bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive …
Direct or early discharge of acute bacterial skin and skin structure infection patients from the emergency department/unit: place in therapy of dalbavancin
A Oliva, S Carbonara, V Cianci, M Crapis… - Expert Review of Anti …, 2023 - Taylor & Francis
ABSTRACT Introduction Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) are a
common reason of Emergency Department (ED) access and account for a considerable …
common reason of Emergency Department (ED) access and account for a considerable …
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an …
F Bai, C Aldieri, AM Cattelan, F Raumer… - Expert Review of Anti …, 2020 - Taylor & Francis
Objectives We evaluated the efficacy and safety of dalbavancin in ABSSSI and 'other sites'
infections'(OTA). Methods Observational study involving 11 Italian hospitals including …
infections'(OTA). Methods Observational study involving 11 Italian hospitals including …
The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs)
Introduction: Acute bacterial skin and skin-structure infections (ABSSSIs) are a subgroup of
skin and soft tissue infections and are a common source of morbidity in both the community …
skin and soft tissue infections and are a common source of morbidity in both the community …
Dalbavancin vs standard of care for Staphylococcus aureus bacteraemia in patients unable to receive outpatient parenteral antimicrobial therapy
Background This study compared dalbavancin with standard of care (SOC) for patients with
Staphylococcus aureus bacteraemia (SAB) who were unable to receive outpatient …
Staphylococcus aureus bacteraemia (SAB) who were unable to receive outpatient …
[HTML][HTML] Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant Staphylococcus aureus: A Retrospective Single-Centre …
Background: Our aim was to describe the clinical outcome and safety of the sequential
treatment with off-label dalbavancin in patients with spondylodiscitis that is caused by …
treatment with off-label dalbavancin in patients with spondylodiscitis that is caused by …
The role of long-acting antibiotics in the clinical practice: a narrative review
G Micheli, M Chiuchiarelli, F Taccari… - Le Infezioni in …, 2023 - pmc.ncbi.nlm.nih.gov
Introduction The increasing emergence of bacterial strains with new resistance determinants
has become a threat to current antibiotic therapies in recent years. This has prompted …
has become a threat to current antibiotic therapies in recent years. This has prompted …